Insights Blog
Explore our thought leadership insights, as life science technologies evolve and accelerate.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Newsletter Update
Diagnostics
Liquid Biopsy | August Round-Up 2026
Liquid Biopsy (LBx) continued to progress in August, featuring positive FDA and Medicare decisions, product launches, study results, and funding.
September 14, 2026
Newsletter Update
Diagnostics
Liquid Biopsy | August Round-Up 2026
Liquid Biopsy (LBx) continued to progress in August, featuring positive FDA and Medicare decisions, product launches, study results, and funding.
September 14, 2026
Liquid Biopsy
.png)
Newsletter Update
Diagnostics
AI Newsletter | August 2026 Round-Up
Read about the latest updates in the AI space in August 2026.
September 8, 2026
Newsletter Update
Diagnostics
AI Newsletter | August 2026 Round-Up
Read about the latest updates in the AI space in August 2026.
September 8, 2026
AI / Machine Learning
.png)
Newsletter Update
Pharma
Next-Generation Therapeutics | August Round-Up 2026
Read about the latest updates in the Next-Generation Therapeutics space in the month of August.
September 2, 2026
Newsletter Update
Pharma
Next-Generation Therapeutics | August Round-Up 2026
Read about the latest updates in the Next-Generation Therapeutics space in the month of August.
September 2, 2026
Next-Generation Therapeutics
Newsletter Update
Investors
Healthcare Investment | August Roundup 2026
August 2026 was defined by aggressive deal-making in metabolic disease, radiopharmaceuticals, rare diseases, and a historic wave of biotech IPOs that collectively raised over $1.2 billion in a single week.
September 1, 2026
Newsletter Update
Investors
Healthcare Investment | August Roundup 2026
August 2026 was defined by aggressive deal-making in metabolic disease, radiopharmaceuticals, rare diseases, and a historic wave of biotech IPOs that collectively raised over $1.2 billion in a single week.
September 1, 2026
Precision Medicine
DeciBio Ventures
Private Equity
DeciBio Q&A
Pharma
Patient Data and the Barriers to Its Potential: DeciBio Q&A with Blanca Baez, Founder at DBounce
In this DeciBio Q&A, Blanca Baez, founder of DBounce, reflects on two decades in pharma, biotech, and AI-driven R&D to discuss the evolving role of patient data.
August 27, 2026
DeciBio Q&A
Pharma
Patient Data and the Barriers to Its Potential: DeciBio Q&A with Blanca Baez, Founder at DBounce
In this DeciBio Q&A, Blanca Baez, founder of DBounce, reflects on two decades in pharma, biotech, and AI-driven R&D to discuss the evolving role of patient data.
August 27, 2026
AI / Machine Learning
Women in Leadership
Clinical Diagnostics
Newsletter Update
Diagnostics
Liquid Biopsy | July Round-Up 2026
Liquid Biopsy (LBx) continued to develop through July, featuring a big acquisition, new regulatory approvals, and study results.
August 13, 2026
Newsletter Update
Diagnostics
Liquid Biopsy | July Round-Up 2026
Liquid Biopsy (LBx) continued to develop through July, featuring a big acquisition, new regulatory approvals, and study results.
August 13, 2026
Liquid Biopsy
Precision Medicine is evolving at a rapid pace
Discover how we can help
Get in Touch
© DeciBio 2023 | All rights reserved